Patent Assignment
Reel/Frame 074976/0089
Security Interest
Recorded: 2026-02-25
Pages: 16
Assignor
NOVAVAX, INC.
Executed: 2026-02-25
Assignee
MIDCAP FINANCIAL TRUST
7255 WOODMONT AVE, SUITE 300, BETHESDA, MARYLAND, 20814
Covered Properties
(68)
Functional Influenza Virus-Like Particles (Vlps)
Functional Influenza Virus Like Particles (Vlps)
Novel Vlps Derived from Cells That Do Not Express a Viral Matrix or Core Protein
Functional Influenza Virus Like Particles (Vlps)
Functional Influenza Virus Like Particles (Vlps)
Modified Rsv F Proteins and Methods of Their Use
Avian Influenza Chimeric Vlps
Virus-Like Particles Comprising Chimeric Human Immunodeficiency Virus (Hiv)/Mouse Mammary Tumor Virus (Mmtv) Envelopes.
Highly Efficient Influenza Matrix (M1) Proteins
Rabies Glycoprotein Virus-Like Particles (Vlps)
Functional Influenza Virus-Like Particles (Vlps)
Functional Influenza Virus-Like Particles (Vlps)
Functional Influenza Virus-Like Particles (Vlps)
Modified Rsv F Proteins and Methods of Their Use
Novel Vlps Derived from Cells That Do Not Express a Viral Matrix or Core Protein
Immunogenic Middle East Respiratory Syndrome Coronavirus (Mers-Cov) Compositions and Methods
Highly Efficient Influenza Matrix (M1) Proteins
Functional Influenza Virus-Like Particles (Vlps)
Modified Rsv F Proteins and Methods of Their Use
Modified Rsv F Proteins and Methods of Their Use
Functional Influenza Virus Like Particles (Vlps)
Modified Rsv F Proteins and Methods of Their Use
Functional Influenza Virus-Like Particles (Vlps)
Vaccine Compositions Having Improved Stability and Immunogenicity
Highly Efficient Influenza Matrix (M1) Proteins
Functional Influenza Virus-Like Particles (Vlps)
Functional Influenza Virus-Like Particles (Vlps)
Functional Influenza Virus Like Particles (Vlps)
Rabies Glycoprotein Virus-Like Particles (Vlps)
Vaccine Compositions Having Improved Stability and Immunogenicity
Functional Influenza Virus-Like Particles (Vlps)
Methods and Compositions for Inducing Immune Responses Against Clostridium Difficile
Highly Efficient Influenza Matrix (M1) Proteins
Modified Rsv F Proteins and Methods of Their Use
Functional Influenza Virus Like Particles (Vlps)
Multivalent Influenza Nanoparticle Vaccines
Vaccine Compositions Having Improved Stability and Immunogenicity
Modified Rsv F Proteins and Methods of Their Use
Methods for Preventing Disease or Disorder Caused by Rsv Infection
Application:
17/433,732 →
Publication:
US 2022/0133875
Coronavirus Vaccine Formulations
Patent:
10,953,089 →
Application:
16/997,001 →
Coronavirus Vaccine Formulations
Application:
17/795,337 →
Publication:
US 2023/0070886
Coronavirus Vaccine Formulations
Coronavirus Vaccine Formulations
Methods and Compositions for Treating Respiratory Disease
Methods and Compositions for Inducing Immune Responses Against Clostridium Difficile
Multivalent Influenza Nanoparticle Vaccines
Coronavirus Vaccine Formulations
Coronavirus Vaccine Formulations
Application:
17/700,945 →
Publication:
US 2022/0332765
Coronavirus and Influenza Compositions and Methods for Using Them
Application:
17/736,452 →
Publication:
US 2022/0354944
Vaccine Compositions Having Improved Stability and Immunogenicity
Modified Rsv F Proteins and Methods of Their Use
Malaria Vaccine Formulations
Application:
18/704,632 →
Publication:
US 2024/0415947
Methods and Compositions for Treating and Preventing Malaria
Application:
18/712,227 →
Publication:
US 2024/0408187
Coronavirus Vaccine Formulations
Application:
18/715,010 →
Publication:
US 2025/0025549
Coronavirus Vaccine Formulations
Anti-Sars-Cov-2 Spike (S) Antibodies and Their Use in Treating Covid-19
Application:
18/723,454 →
Publication:
US 2025/0066456
Downstream Process for Purification of Viral Proteins with Hydrophobic Membrane Domain for Use in Vaccine Compositions
Application:
18/458,789 →
Publication:
US 2024/0076320
Coronavirus Vaccine Formulations
Coronavirus and Influenza Compositions and Methods for Using Them
Application:
18/626,201 →
Publication:
US 2024/0325523
Sars-Cov-2 Vaccine Compositions
Application:
18/645,259 →
Publication:
US 2024/0374712
Methods and Compositions for Treating Respiratory Disease
Application:
18/828,852 →
Publication:
US 2024/0423926
Method for Detecting Anti-Sars-Cov-2 Spike (S) Immunoglobulins
Application:
18/882,452 →
Publication:
US 2025/0085282
Anti-Sars-Cov-2 Spike (S) Antibodies and Their Use in Treating Covid-19
Application:
18/900,674 →
Publication:
US 2025/0109187
Compositions and Methods for Inducing an Immune Response Against Epstein-Barr Virus
Application:
18/853,030 →
Publication:
US 2025/0325646
Intranasal Immunogenic Compositions
Application:
18/939,463 →
Publication:
US 2025/0144200
Pseudovirus Based Neutralization Assay for Evaluating Vaccine Immunogenicity
Application:
18/998,469 →
Publication:
US 2026/0028644
ACE2 Inhibition Assay for Evaluation of Vaccine Immunogenicity
Application:
18/998,471 →
Avian Influenza Nanoparticle Immunogenic Compositions
Application:
19/070,329 →
Publication:
US 2025/0276054
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 3, 2007
From: SMITH, GALE; BRIGHT, RICH; PUSHKO, PETER; ZHANG, JINYOU
To: NOVARVAX, INC.
Reel/Frame 019139/0464 →
Corrective Assignment to Correct the Assignor #2: Rick Bright and Assignee: Novavax, Inc. Previously Recorded on Reel 019139 Frame 0464. Assignor(S) Hereby Confirms the Assignor #2 from <Rich> Bright to <Rick> Bright and Receiving Party from <Novarvax>, Inc. to <Novavax>, Inc..
May 9, 2007
From: SMITH, GALE; BRIGHT, RICK; PUSHKO, PETER; ZHANG, JINYOU
To: NOVAVAX, INC.
Reel/Frame 019267/0668 →
Assignment of Assignor's Interest
Apr 4, 2008
From: ROBINSON, ROBIN A.; PUSHKO, PETER M.
To: NOVAVAX, INC.
Reel/Frame 020756/0793 →
Assignment of Assignor's Interest
Aug 27, 2009
From: SMITH, GALE; PUSHKO, PETER; MAHMOOD, KUTUB; ZHOU, BIN
To: NOVAVAX, INC.
Reel/Frame 023156/0856 →
Assignment of Assignor's Interest
Mar 25, 2010
From: SMITH, GALE; PUSHKO, PETER
To: NOVAVAX, INC.
Reel/Frame 024134/0286 →
Assignment of Assignor's Interest
Mar 31, 2010
From: COMPANS, RICHARD W.; WANG, BAOZHONG
To: EMORY UNIVERSITY
Reel/Frame 024166/0766 →
Assignment of Assignor's Interest
Mar 31, 2010
From: HAHN, BEATRICE; LIU, WEIMIN
To: UNIVERSITY OF ALABAMA
Reel/Frame 024166/0971 →
Assignment of Assignor's Interest
Mar 31, 2010
From: SMITH, GALE; PUSHKO, PETER
To: NOVAVAX, INC.
Reel/Frame 024166/0796 →
Assignment of Assignor's Interest
Jun 7, 2010
From: PUSHKO, PETER; WU, YINGYUN; MASSARE, MICHAEL; LIU, YE
To: NOVAVAX, INC.
Reel/Frame 024494/0933 →
Assignment of Assignor's Interest
Apr 24, 2012
From: SMITH, GALE; BRIGHT, RICK; PUSHKO, PETER M.; ZHANG, JINYOU
To: NOVAVAX, INC.
Reel/Frame 028098/0135 →
Assignment of Assignor's Interest
May 15, 2012
From: SMITH, GALE; BRIGHT, RICK; PUSHKO, PETER; ZHANG, JINYOU
To: NOVAVAX, INC.
Reel/Frame 028209/0223 →
Assignment of Assignor's Interest
Aug 1, 2012
From: HAHN, BEATRICE; LIU, WEIMIN
To: THE UAB RESEARCH FOUNDATION
Reel/Frame 028695/0175 →
Assignment of Assignor's Interest
Jan 23, 2013
From: SMITH, GALE; WU, YINGYUN; MASSARE, MICHAEL; PUSHKO, PETER
To: NOVAVAX INC.
Reel/Frame 029677/0032 →
Assignment of Assignor's Interest
Oct 28, 2013
From: SMITH, GALE; BRIGHT, RICK; PUSHKO, PETER M.; ZHANG, JINYOU
To: NOVAVAX, INC.
Reel/Frame 031491/0976 →
Assignment of Assignor's Interest
Oct 28, 2013
From: SMITH, GALE; LIU, YE
To: NOVAVAX, INC.
Reel/Frame 031491/0897 →
Assignment of Assignor's Interest
Oct 28, 2013
From: ROBINSON, ROBIN A.; PUSHKO, PETER M.
To: NOVAVAX, INC.
Reel/Frame 031491/0718 →
Assignment of Assignor's Interest
Feb 9, 2015
From: SMITH, GALE; PUSHKO, PETER; MAHMOOD, KUTUB; ZHOU, BIN
To: NOVAVAX, INC.
Reel/Frame 034920/0608 →
Assignment of Assignor's Interest
Feb 9, 2015
From: PUSHKO, PETER; WU, YINGYUN; MASSARE, MICHAEL; LIU, YE
To: NOVAVAX, INC.
Reel/Frame 034920/0468 →
Assignment of Assignor's Interest
Apr 2, 2015
From: SMITH, GALE; BRIGHT, RICK; PUSHKO, PETER; ZHANG, JINYOU
To: NOVAVAX, INC.
Reel/Frame 035318/0279 →
Assignment of Assignor's Interest
Aug 6, 2015
From: SMITH, GALE; WU, YINGYUN; MASSARE, MICHAEL; PUSHKO, PETER
To: NOVAVAX, INC.
Reel/Frame 036271/0729 →
Assignment of Assignor's Interest
Aug 2, 2016
From: SMITH, GALE; LIU, YE; MASSARE, MICHAEL
To: NOVAVAX, INC.
Reel/Frame 039319/0754 →